These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24098713)

  • 61. Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice.
    Gangadharan Komala M; Gross S; Mudaliar H; Huang C; Pegg K; Mather A; Shen S; Pollock CA; Panchapakesan U
    PLoS One; 2014; 9(11):e108994. PubMed ID: 25369239
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Protein conjugated with aldehydes derived from lipid peroxidation as an independent parameter of the carbonyl stress in the kidney damage.
    Medina-Navarro R; Nieto-Aguilar R; Alvares-Aguilar C
    Lipids Health Dis; 2011 Nov; 10():201. PubMed ID: 22059738
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats.
    Yamabe N; Yokozawa T; Oya T; Kim M
    J Pharmacol Exp Ther; 2006 Oct; 319(1):228-36. PubMed ID: 16835369
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress.
    Ma T; Zheng Z; Guo H; Lian X; Rane MJ; Cai L; Kim KS; Kim KT; Zhang Z; Bi L
    Toxicol Appl Pharmacol; 2019 May; 370():93-105. PubMed ID: 30876865
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.
    Mifsud S; Kelly DJ; Qi W; Zhang Y; Pollock CA; Wilkinson-Berka JL; Gilbert RE
    Nephron Physiol; 2003; 95(4):p83-91. PubMed ID: 14694265
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
    Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Small Molecule Inhibiting Nuclear Factor-kB Ameliorates Oxidative Stress and Suppresses Renal Inflammation in Early Stage of Alloxan-Induced Diabetic Nephropathy in Rat.
    Borgohain MP; Lahkar M; Ahmed S; Chowdhury L; Kumar S; Pant R; Choubey A
    Basic Clin Pharmacol Toxicol; 2017 May; 120(5):442-449. PubMed ID: 27888584
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes.
    Sakai S; Yamamoto T; Takabatake Y; Takahashi A; Namba-Hamano T; Minami S; Fujimura R; Yonishi H; Matsuda J; Hesaka A; Matsui I; Matsusaka T; Niimura F; Yanagita M; Isaka Y
    J Am Soc Nephrol; 2019 Jun; 30(6):929-945. PubMed ID: 31040190
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of training and nitric oxide on diabetic nephropathy progression in type I diabetic rats.
    Rodrigues AM; Bergamaschi CT; Araújo RC; Mouro MG; Rosa TS; Higa EM
    Exp Biol Med (Maywood); 2011 Oct; 236(10):1180-7. PubMed ID: 21930716
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Experimental treatment of complications in alloxan diabetic rats with alpha-glucosidase inhibitor from the Chinese medicinal herb ramulus mori.
    Ye F; Shen ZF; Qiao FX; Zhao DY; Xie MZ
    Yao Xue Xue Bao; 2002 Feb; 37(2):108-12. PubMed ID: 12579953
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
    Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
    J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gallic acid improves the metformin effects on diabetic kidney disease in mice.
    Hong Y; Wang J; Sun W; Zhang L; Xu X; Zhang K
    Ren Fail; 2023 Dec; 45(1):2183726. PubMed ID: 37723077
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Exogenous activated protein C inhibits the progression of diabetic nephropathy.
    Gil-Bernabe P; D'Alessandro-Gabazza CN; Toda M; Boveda Ruiz D; Miyake Y; Suzuki T; Onishi Y; Morser J; Gabazza EC; Takei Y; Yano Y
    J Thromb Haemost; 2012 Mar; 10(3):337-46. PubMed ID: 22236035
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Platycodin D inhibits HFD/STZ-induced diabetic nephropathy via inflammatory and apoptotic signaling pathways in C57BL/6 mice.
    Shen Q; Qi SM; Zhang JT; Li MH; Wang YP; Wang Z; Li W
    J Ethnopharmacol; 2023 Oct; 314():116596. PubMed ID: 37146841
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase.
    Fujii M; Inoguchi T; Sasaki S; Maeda Y; Zheng J; Kobayashi K; Takayanagi R
    Kidney Int; 2010 Nov; 78(9):905-19. PubMed ID: 20686447
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
    Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
    Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HPLC analysis of naturally occurring methylated catechins, 3' '- and 4' '-methyl-epigallocatechin gallate, in various fresh tea leaves and commercial teas and their potent inhibitory effects on inducible nitric oxide synthase in macrophages.
    Chiu FL; Lin JK
    J Agric Food Chem; 2005 Sep; 53(18):7035-42. PubMed ID: 16131108
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epigallocatechin-3-O-(3-O-methyl)-gallate-induced differentiation of human keratinocytes involves klotho-mediated regulation of protein kinase-cAMP responsive element-binding protein signaling.
    Kim HJ; Chang H; Han SH; Lee MS; Jung JY; An S; Baek SY; Lee JH; Lee JH; Lee TR; Shin DW; Kim H
    Int J Mol Sci; 2014 Apr; 15(4):5749-61. PubMed ID: 24714085
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Renoprotective effects of berberine and its potential effect on the expression of β-arrestins and intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in streptozocin-diabetic nephropathy rats.
    Tang LQ; Ni WJ; Cai M; Ding HH; Liu S; Zhang ST
    J Diabetes; 2016 Sep; 8(5):693-700. PubMed ID: 26531813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.